Mescaline

Mescaline
Clinical data
Other namesMescalin; Mezcalin; Mezcaline; 3,4,5-Trimethoxyphenethylamine; 3,4,5-TMPEA; TMPEA
AHFS/Drugs.commescaline
Routes of
administration
Oral, smoking, insufflation, intravenous[1][2]
Drug classSerotonin receptor agonist; Serotonergic psychedelic; Hallucinogen
ATC code
  • None
Legal status
Legal status
  • AU: S9 (Prohibited substance)
  • BR: Class F2 (Prohibited psychotropics)[3]
  • CA: Schedule III , except peyote
  • DE: Anlage I (Authorized scientific use only)
  • UK: Class A (Plants containing mescaline legal)
  • US: Schedule I
  • UN: Psychotropic Schedule I
Pharmacokinetic data
BioavailabilityUnknown (but ≥53%)[4][5]
Protein bindingUnknown[5]
MetabolismOxidative deamination, N-acetylation, O-demethylation, conjugation, other pathways[6][7]
Metabolites• 3,4,5-Trimethoxyphenyl-acetaldehyde[6][1]
• 3,4,5-Trimethoxyphenylacetic acid[1]
• 3,4,5-Trimethoxyphenylethanol[7]
• Others[6][7][2]
Onset of actionOral: 0.5–0.9 hours (range 0.1–2.7 hours)[8][9][1]
Elimination half-life3.6 hours (range 2.6–5.3 hours)[8][10][9][4]
Duration of action6.4–14 hours (range 3.0–22 hours)[8][1][9]
ExcretionUrine (≥92%; 28–60% unchanged, ≥27–31% as TMPAA, 5% as N-Ac-3,4-DiMeO-5-OH-PEA, <0.1% as NAMTooltip N-acetylmescaline)[1][4][11][2][6][7][12]
Identifiers
IUPAC name
  • 2-(3,4,5-trimethoxyphenyl)ethanamine
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
PDB ligand
CompTox Dashboard (EPA)
ECHA InfoCard100.000.174
Chemical and physical data
FormulaC11H17NO3
Molar mass211.261 g·mol−1
3D model (JSmol)
Density1.067 g/cm3
Melting point35 to 36 °C (95 to 97 °F)
Boiling point180 °C (356 °F) at 12 mmHg
Solubility in watermoderately soluble in water mg/mL (20 °C)
SMILES
  • O(c1cc(cc(OC)c1OC)CCN)C
InChI
  • InChI=1S/C11H17NO3/c1-13-9-6-8(4-5-12)7-10(14-2)11(9)15-3/h6-7H,4-5,12H2,1-3H3 Y
  • Key:RHCSKNNOAZULRK-UHFFFAOYSA-N Y
  (verify)

Mescaline, also known as mescalin or mezcalin,[13] and in chemical terms 3,4,5-trimethoxyphenethylamine, is a naturally occurring psychedelic protoalkaloid of the substituted phenethylamine class, found in cacti like peyote (Lophophora williamsii) and San Pedro (certain species of the genus Echinopsis) and known for its serotonergic hallucinogenic effects.[6][1][8]

Mescaline is typically taken orally and used recreationally, spiritually, and medically, with psychedelic effects occurring at doses from 100 to 1,000 mg, including microdosing below 75 mg, and it can be consumed in pure form or via mescaline-containing cacti. Mescaline induces a psychedelic experience characterized by vivid visual patterns, altered perception of time and self, synesthesia, and spiritual effects, with an onset of 0.5 to 0.9 hours and a duration that increases with dose, ranging from about 6 to 14 hours. Mescaline has a high median lethal dose across species, with the human LD50 estimated at approximately 880 mg/kg, making it very difficult to consume a fatal amount. Ketanserin blocks mescaline’s psychoactive effects, and while it's unclear if mescaline is metabolized by monoamine oxidase enzymes, but preliminary evidence suggests harmala alkaloids may potentiate its effects.

Mescaline primarily acts as a partial agonist at serotonin 5-HT2A receptors, with varying affinity and efficacy across multiple serotonin, adrenergic, dopamine, histamine, muscarinic, and trace amine receptors, but shows low affinity for most non-serotonergic targets. It is a relatively hydrophilic psychedelic compound structurally related to catecholamines but acting on the serotonergic system, first synthesized in 1919, with numerous synthetic methods and potent analogues developed since. Mescaline occurs naturally in various cacti species, with concentrations varying widely, and is biosynthesized in plants from phenylalanine via catecholamine pathways likely linked to stress responses.

Mescaline-containing cacti use dates back over 6,000 years.[6] Peyote was studied scientifically in the 19th and 20th centuries, culminating in the isolation of mescaline as its primary psychoactive compound, legal recognition of its religious use, and ongoing exploration of its therapeutic potential. Mescaline is largely illegal worldwide, though exceptions exist for religious, scientific, or ornamental use, and it has influenced many notable cultural figures through its psychoactive effects. Very few studies concerning mescaline's activity and potential therapeutic effects in people have been conducted since the early 1970s.

  1. ^ a b c d e f g Vamvakopoulou IA, Narine KA, Campbell I, Dyck JR, Nutt DJ (January 2023). "Mescaline: The forgotten psychedelic". Neuropharmacology. 222: 109294. doi:10.1016/j.neuropharm.2022.109294. PMID 36252614.
  2. ^ a b c Cite error: The named reference Dinis-OliveiraPereiradaSilva2019 was invoked but never defined (see the help page).
  3. ^ Anvisa (24 July 2023). "RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 804 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 25 July 2023). Archived from the original on 27 August 2023. Retrieved 27 August 2023.
  4. ^ a b c Cite error: The named reference MuellerKlaiberLey2025 was invoked but never defined (see the help page).
  5. ^ a b "Mescaline: Uses, Interactions, Mechanism of Action". DrugBank Online. 3 July 2024. Retrieved 19 May 2025.
  6. ^ a b c d e f Cassels BK, Sáez-Briones P (October 2018). "Dark Classics in Chemical Neuroscience: Mescaline". ACS Chem Neurosci. 9 (10): 2448–2458. doi:10.1021/acschemneuro.8b00215. PMID 29847089.
  7. ^ a b c d Cite error: The named reference Doesburg-vanKleffensZimmermann-KlemdGründemann2023 was invoked but never defined (see the help page).
  8. ^ a b c d Holze F, Singh N, Liechti ME, D'Souza DC (May 2024). "Serotonergic Psychedelics: A Comparative Review of Efficacy, Safety, Pharmacokinetics, and Binding Profile". Biol Psychiatry Cogn Neurosci Neuroimaging. 9 (5): 472–489. doi:10.1016/j.bpsc.2024.01.007. PMID 38301886.
  9. ^ a b c Cite error: The named reference KlaiberSchmidBecker2024 was invoked but never defined (see the help page).
  10. ^ Cite error: The named reference LeyHolzeArikci2023 was invoked but never defined (see the help page).
  11. ^ Cite error: The named reference Patel1968 was invoked but never defined (see the help page).
  12. ^ Cite error: The named reference CharalampousWalkerKinross-Wright1966 was invoked but never defined (see the help page).
  13. ^ "Mescaline". PubChem. U.S. National Library of Medicine. Retrieved 22 October 2024.